紀建光

Provide evidence-based clinical guidance to advance precision medicine practices.

Investigate environmental and genetic factors contributing to the development of common cancers and chronic diseases, such as diabetes and cardiovascular diseases.

1. Yi H, Zheng X, Ji J: Levonorgestrel-releasing intrauterine device use and risk of gynecologic and breast cancers: the need for further evidence. Am J Obstet Gynecol 2025.
2. Yi H, Zhang N, Sundquist J, Sundquist K, Zheng X, Ji J: Long-term outcomes after unilateral salpingo-oophorectomy: A registry-based retrospective cohort study. PLoS Med 2025, 22(7):e1004639.
3. Wang D, Ji J: Timing matters in diagnosis of cancer with immune-mediated inflammatory disease. Nat Rev Rheumatol 2025.
4. Liu Y, Sundquist J, Sundquist K, Ji J: Exploring the Influence of Parental Mental Illness on Childhood Cancer Mortality: A Nationwide Cohort Study in Sweden. J Natl Compr Canc Netw 2025:1-7.
5. Zheng G, Chattopadhyay S, Sundquist J, Sundquist K, Ji J. Antihypertensive drug targets and breast cancer risk: A two-sample mendelian randomization study. European Journal of Epidemiology. 2024;39(5):535-548.
6. Yi H, Zhang N, Huang J, Zheng Y, Hong QH, Sundquist J, Sundquist K, Zheng X, Ji J. Association of levonorgestrel-releasing intrauterine device with gynecologic and breast cancers: A national cohort study in sweden. American Journal of Obstetrics and Gynecology. 2024;231(4):450 e1-450 e12.
7. Yi H, Ji J. Uncovering causal clues in the development of second primary cancers. Lancet Oncology. 2024;25(3):e97.
8. Liu Y, Jiang Z, Sundquist J, Sundquist K, Ji J. Long-term pattern of psychotropic medication uses among swedish parents of children diagnosed with cancer. J Natl Compr Canc Netw. 2024;22(9)
9. Zheng D, Li N, Hou R, Zhang X, Wu L, Sundquist J, Sundquist K, Ji J. Glucagon-like peptide-1 receptor agonists and diabetic retinopathy: Nationwide cohort and mendelian randomization studies. BMC Medicine. 2023;21(1):40.
10. Zhang N, Li Y, Sundquist J, Sundquist K, Ji J. Identifying actionable druggable targets for breast cancer: Mendelian randomization and population-based analyses. EBioMedicine. 2023;98:104859.
11. Liu Y, Sundquist J, Sundquist K, Zheng D, Ji J. Mental health outcomes in parents of children with a cancer diagnosis in sweden: A nationwide cohort study. EClinicalMedicine. 2023;55:101734.
12. Zhang N, Sundquist J, Sundquist K, Ji J. Proguanil and atovaquone use is associated with lower colorectal cancer risk: A nationwide cohort study. BMC Medicine. 2022;20(1):439.
13. Huang W, Sundquist K, Sundquist J, Ji J. Use of dipyridamole is associated with lower risk of lymphoid neoplasms: A propensity score-matched cohort study. British Journal of Haematology. 2022;196(3):690-699.
14. Hu LP, Huang W, Wang X, Xu C, Qin WT, Li D, Tian G, Li Q, Zhou Y, Chen S, et al. Terbinafine prevents colorectal cancer growth by inducing dntp starvation and reducing immune suppression. Molecular Therapy. 2022;30(10):3284-3299.
15. Zheng G, Sundquist J, Sundquist K, Ji J. Association of post-diagnostic use of cholera vaccine with survival outcome in breast cancer patients. British Journal of Cancer. 2021;124(2):506-512.
16. Zhang N, Sundquist J, Sundquist K, Zhang ZG, Ji J. Combined use of aspirin and selective serotonin reuptake inhibitors is associated with lower risk of colorectal cancer: A nested case-control study. American Journal of Gastroenterology. 2021;116(6):1313-1321.
17. Huang W, Xiao J, Ji J, Chen L. Association of lipid-lowering drugs with covid-19 outcomes from a mendelian randomization study. Elife. 2021;10
18. Huang W, Sundquist J, Sundquist K, Ji J. Phosphodiesterase-5 inhibitors use and risk for mortality and metastases among male patients with colorectal cancer. Nat Commun. 2020;11(1):3191.
19. Hemminki K, Huang W, Sundquist J, Sundquist K, Ji J. Autoimmune diseases and hematological malignancies: Exploring the underlying mechanisms from epidemiological evidence. Seminars in Cancer Biology. 2020;64:114-121.
20. Huang W, Sundquist J, Sundquist K, Ji J. Use of phosphodiesterase 5 inhibitors is associated with lower risk of colorectal cancer in men with benign colorectal neoplasms. Gastroenterology. 2019;157(3):672-681 e4.
21. Ji J, Sundquist J, Sundquist K. Cholera vaccine use is associated with a reduced risk of death in patients with colorectal cancer: A population-based study. Gastroenterology. 2018;154(1):86-92 e1.
22. Ji J, Sundquist J, Sundquist K. Association between post-diagnostic use of cholera vaccine and risk of death in prostate cancer patients. Nat Commun. 2018;9(1):2367.
23. Ji J, Chen T, Sundquist J, Sundquist K. Type 1 diabetes in parents and risk of attention deficit/hyperactivity disorder in offspring: A population-based study in sweden. Diabetes Care. 2018;41(4):770-774.
24. Ji J, Sundquist J, Sundquist K. Gender-specific incidence of autoimmune diseases from national registers. Journal of Autoimmunity. 2016;69:102-6.
25. Ji J, Sundquist J, Sundquist K. Incidence and familial risk of pleural mesothelioma in sweden: A national cohort study. European Respiratory Journal. 2016;48(3):873-9.
26. Ji J, Sundquist J, Sundquist K. Tonsillectomy associated with an increased risk of autoimmune diseases: A national cohort study. Journal of Autoimmunity. 2016;72:1-7.
27. Kendler KS, Ji J, Edwards AC, Ohlsson H, Sundquist J, Sundquist K. An extended swedish national adoption study of alcohol use disorder. JAMA Psychiatry. 2015;72(3):211-8.
28. Sundquist J, Sundquist K, Ji J. Autism and attention-deficit/hyperactivity disorder among individuals with a family history of alcohol use disorders. Elife. 2014;3:e02917.
29. Ji J, Sundquist K, Ning Y, Kendler KS, Sundquist J, Chen X. Incidence of cancer in patients with schizophrenia and their first-degree relatives: A population-based study in sweden. Schizophrenia Bulletin. 2013;39(3):527-36.
30. Ji J, Zoller B, Sundquist K, Sundquist J. Increased risks of coronary heart disease and stroke among spousal caregivers of cancer patients. Circulation. 2012;125(14):1742-7.